A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome

Panitumumab is a recombinant human IgG(2) monoclonal antibody which is used for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or following FOLFIRI (fluoropyrimidine, oxaliplatin and irinotecan) containing chemotherapy regimen. We report a case of an 8...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Case Rep
Main Authors: Rezkallah, Kamal Naguib Makar, Ahmed, Adnan, Patel, Sabah, Kozma, Kelly
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2019
Teme:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6441272/
https://ncbi.nlm.nih.gov/pubmed/30739089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-227785
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki